{"id":"NCT00978380","sponsor":"Novo Nordisk A/S","briefTitle":"Safety of Monthly Recombinant Factor XIII Replacement Therapy in Subjects With Congenital Factor XIII Deficiency: An Extension to Trial F13CD-1725","officialTitle":"A Multi-Centre, Open-Label, Single-Arm, and Multiple Dosing Trial on Safety of Monthly Replacement Therapy With Recombinant Factor XIII (rFXIII) in Subjects With Congenital Factor XIII Deficiency","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-09-21","primaryCompletion":"2015-10-20","completion":"2015-10-20","firstPosted":"2009-09-16","resultsPosted":"2016-12-13","lastUpdate":"2018-01-24"},"enrollment":63,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Congenital Bleeding Disorder","Congenital FXIII Deficiency"],"interventions":[{"type":"DRUG","name":"catridecacog","otherNames":["recombinant factor XIII"]}],"arms":[{"label":"A","type":"EXPERIMENTAL"}],"summary":"This trial is conducted in Asia, Europe and North America. The aim of the trial is to investigate the safety of monthly replacement therapy of recombinant factor XIII in patients with congenital FXIII deficiency. The trial continues until the product is commercially available, but an interim assessment will take place when all subjects have completed 52 weeks in the trial.","primaryOutcome":{"measure":"Adverse Events (AEs)(Serious and Non-serious)","timeFrame":"All AEs were collected and reported from screening (week 0) for a minimum period of 52 weeks or until the end of trial visit.","effectByArm":[{"arm":"Recombinant Factor XIII (rFXIII)","deltaMin":920,"sd":null}],"pValues":[]},"eligibility":{"minAge":"6 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":4},"locations":{"siteCount":34,"countries":["United States","Austria","Canada","Finland","France","Germany","Israel","Italy","Japan","Spain","Switzerland","United Kingdom"]},"refs":{"pmids":["25643920","25263390","37883802"],"seeAlso":["http://novonordisk-trials.com"]},"adverseEventsSummary":{"seriousAny":{"events":12,"n":59},"commonTop":["Headache","Nasopharyngitis","Upper respiratory tract infection","Contusion","Pain in extremity"]}}